Loading...

T. Rowe Price Health Sciences Fund

PRHSXNASDAQ
Financial Services
Asset Management
$76.56
$-0.85(-1.10%)

T. Rowe Price Health Sciences Fund (PRHSX) Stock Overview

Explore T. Rowe Price Health Sciences Fund’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.8/100

Key Financials

Market Cap12.6B
P/E RatioN/A
EPS (TTM)$2.64
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Week$76.93
1 Month$78.06
3 Months$82.18
1 Year Target$89.55

PRHSX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of T. Rowe Price Health Sciences Fund (PRHSX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

58.25RSI (14)
0.44MACD
13.32ADX
Stats data is not available for PRHSXStats details for PRHSX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for PRHSXAnalyst Recommendations details for PRHSX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.

Headquarters

T. Rowe Price Health Sciences Fund, Inc., MD

Founded

1995

Frequently Asked Questions

;